Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan · Delayed Price · Currency is TWD 78.60
+0.10 (0.13%)
Oct 31, 2025, 2:31 PM CST
Foresee Pharmaceuticals Market Cap
Foresee Pharmaceuticals has a market cap or net worth of 12.17 billion as of October 31, 2025. Its market cap has increased by 8.02% in one year.
Market Cap
12.17B
Enterprise Value
11.56B
Revenue
442.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
78.60
Market Cap Chart
Since April 12, 2016, Foresee Pharmaceuticals's market cap has increased from 7.35B to 12.17B, an increase of 65.58%. That is a compound annual growth rate of 5.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 12.17B | 1.47% |
| Dec 31, 2024 | 12.00B | -8.16% |
| Dec 29, 2023 | 13.06B | 20.98% |
| Dec 30, 2022 | 10.80B | -23.14% |
| Dec 30, 2021 | 14.05B | 34.12% |
| Dec 31, 2020 | 10.47B | 79.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |